US

Hamilton Lane announces leadership appointments

The private markets asset management firm has named Jeff Armbrister as global head of co-investments and Mingchen Xia and Collwyn Tan as co-heads of Asia investments.

Phoenix Molecular secures seed funding

Vancouver, British Columbia and San Diego-based Phoenix Molecular, a developer of precise cancer therapeutics targeting essential kinases, has raised US$12 million in seed funding. The investors included Pallasite Ventures and World Changing Ventures.

Symphony Technology Group nears sale of First Advantage

Symphony Technology Group is close to finding a buyer for First Advantage, a background screening software company the firm acquired nine years ago, four sources familiar with the process told Buyouts.

Vouch Insurance seals $45 mln Series B

San Francisco and Chicago-based Vouch Insurance, an insurance company serving early-stage startups, has secured $45 million in Series B funding. Y Combinator Continuity led the round.

.406 Ventures wraps up fourth fund

Boston-based .406 Ventures, a venture firm that invests in early-stage enterprise tech and digital health companies, has closed its fourth fund at $294 million, beating its $225 million target. Also, the firm has promoted Payal Agrawal Divakaran to partner as well as hired Kevin Wang as an associate and Joseph SantaBarbara as controller.

Lucence garners $20 mln Series A

Singapore-based Lucence, a genomic medicine company, has secured $20 million in Series A funding. IHH Healthcare led the round.

Gravitational pulls in $25 mln Series in Kleiner Perkins-led round

Oakland, California-based Gravitational, a provider of infrastructure software solutions, has raised $25 million in Series A funding. Kleiner Perkins led the round.

CincyTech targets $50 mln for fifth fund

CincyTech is seeking to raise $50 million for its fifth fund, according to an SEC filing. The seed-stage firm invests in tech companies in Southwest Ohio.